CSIMarket
 
Keenova Therapeutics Plc  (MNK)
 

Keenova Therapeutics Plc's Customers Performance

MNK



 
MNK's Source of Revenues During the corresponding time, Keenova Therapeutics Plc recorded a revenue increase by 11.36 % year on year, While revenue at the Keenova Therapeutics Plc's corporate clients

List of MNK Customers




for the same period Keenova Therapeutics Plc recorded revenue increase by 11.36 % year on year,

List of MNK Customers

Keenova Therapeutics Plc's Business Units
Rebates and Chargebacks    41.7 % of total Revenue
Product Returns    1.39 % of total Revenue
Other Sales Deductions    1.05 % of total Revenue
Transferred at Point in Time    0 % of total Revenue
Transferred over Time    0 % of total Revenue
Acthar Gel    36.25 % of total Revenue
Xiaflex    28.74 % of total Revenue
INOmax    12.57 % of total Revenue
Amitiza    4.49 % of total Revenue
Other Products    16.83 % of total Revenue
License Revenue    1.26 % of total Revenue
Single Reportable    210.76 % of total Revenue






Keenova Therapeutics Plc's Comment on Sales, Marketing and Customers



The company serves customers including Group Purchasing Organizations (GPOs), integrated delivery networks (IDNs), third-party payers, governmental organizations, affiliated hospitals, and other members of GPOs and IDNs. These customers negotiate pricing and award contracts through competitive bidding processes. The company also sells products to governmental purchasing agents outside the U.S., where centralized healthcare authorities require competitive bidding. Additionally, distributors form strategic alliances and negotiate sales terms with the company. The company operates in markets characterized by pricing pressures and competitive challenges.





Keenova Therapeutics Plc’s Comment on Sales, Marketing and Customers


The company serves customers including Group Purchasing Organizations (GPOs), integrated delivery networks (IDNs), third-party payers, governmental organizations, affiliated hospitals, and other members of GPOs and IDNs. These customers negotiate pricing and award contracts through competitive bidding processes. The company also sells products to governmental purchasing agents outside the U.S., where centralized healthcare authorities require competitive bidding. Additionally, distributors form strategic alliances and negotiate sales terms with the company. The company operates in markets characterized by pricing pressures and competitive challenges.








MNK's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Keenova Therapeutics Plc 13.47 1,818.00 -576.80 1,600
SUBTOTAL 0.00 0.00 0.00 -

Sources: Keenova Therapeutics Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Keenova Therapeutics Plc’s corporate clients.
For your research, we’ve provided 9 tables on Keenova Therapeutics Plc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.